logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us

中/EN

logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us
  • 重酒石酸去甲肾上腺素喜报
    Congratulations to the approval of API Norepinephrine Bitartrate!
  • 展会邀请函
    Wanhan Pharmaceutical Company 丨 visit us at booth No.6 in the 18th Annual Meeting of the Chinese Physicians Association of Ophthalmology
  • 展会邀请函
    Wanhan Pharmaceutical Company 丨 Visit us at Booth A4E46 during the 89th PharmChina.
  • 展会邀请函
    Wanhan Pharmaceutical Company 丨 Visit us at Booth B17 during the 10th Chinese Dry Eye Congress.
  • 盐酸兰地洛尔
    WANHAN PHARMACEUTICAL COMPANY: Landiolol Hydrochloride API has been successfully authorized.
  • 1-2
    Diquafosol sodium eye drops have been officially approved
  • 2-1
    We invite you to visit the 28th Chinese Medical Association Ophthalmology Conference stand A4008 for guidance and negotiation
  • 3-2
    We invite you to visit our booth P03 to guide and negotiate
  • 1
  • 2
  • 3
  • 4
  • 5

Contact Us

Foreign Trade Email:

Foreign-Trade@whpt.com.cn              

Foreign-Trade1@whpt.com.cn 

 

Foreign Trade:

+86 139-2498-2439 (WhatsApp,WeChat)
+86 189-8859-3463

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.